The current bulletin for Community Health, produced by Merseycare NHS Foundation Trust, is now available to view and download.
For support accessing any of the articles within the bulletin please contact: academic.library@lscft.nhs.uk
Please find the latest Quality Improvement bulletin produced by NHS Somerset Foundation Trust.
If you missed the BBC radio 4 series Is Psychiatry Working? it is available on BBC Sounds and an intriguing listen. Writer Horatio Clare (who himself had a breakdown a few years ago) and psychiatrist Professor Femi Oyebode discuss the issues and concerns around crisis, detention, diagnosis, medication, therapy and healing and recovery.
Please find the latest Forensic Psychiatry and Rehabilitation and Recovery bulletins produced by Greater Manchester Mental Health Trust. If you have difficulties accessing any of the articles please contact the library on academic.library@lscft.nhs.uk.
Health Education England is carrying out a survey into NHS library and knowledge service users’ use of grey literature. Do you routinely use source materials that are not published in journals (example unpublished research, conference papers, service evaluation reports, government documents, posters and QI projects) or do you actively avoid them? Fil in the survey to help Health Education England know what you use and need from such resources.
The current bulletin for Dementia, produced by Merseycare NHS Foundation Trust, is now available to view and download.
For support accessing any of the articles within the bulletins please contact: academic.library@lscft.nhs.uk
Slowing progression of, rather than stopping, Alzheimer’s disease has measurable benefits for patients and families and may be a more realistic goal for clinical drug trials, a new report by the American Alzheimer’s Association has suggested.
The report‘s authors call for a “reframing” of how researchers define “clinically meaningful” in randomized controlled trials, adding that they consider it is time to adjust expectations of outcomes from relatively short clinical trials.
The report was published by an expert work group convened by the Alzheimer’s Association. It was prompted, in part, by the US Food and Drug Administration’s controversial decision to grant aducanumab (Aduhelm) accelerated approval, which came over the objection of an advisory panel that found the drug was ineffective.
Slowing, Not Stopping, Alzheimer’s a Better Goal for Drug Trials? (medscape.com)
Please find the latest Digital Mental Health Bulletin, produced by Greater Manchester Mental Health Trust. If you have difficulties accessing any of the articles please contact the library on academic.library@lscft.nhs.uk.
The current bulletin for Suicide Prevention, produced by Merseycare NHS Foundation Trust, is now available to view and download.
For support accessing any of the articles within the bulletins please contact: academic.library@lscft.nhs.uk
The Wellcome Trust is funding a new study and clinical trial that will further investigate the effectiveness of cannabidiol (CBD) in treating people with psychosis. Work carried out by Oxford University and King’s College London will look at whether CBD can be used not only to treat established psychosis, but also to prevent the onset of psychosis in people at high risk of developing it.
Is CBD the future of antipsychotic drugs? | News | Wellcome
